A Mutation in Rab27a Causes the Vesicle Transport Defects Observed in Ashen Mice

Total Page:16

File Type:pdf, Size:1020Kb

A Mutation in Rab27a Causes the Vesicle Transport Defects Observed in Ashen Mice A mutation in Rab27a causes the vesicle transport defects observed in ashen mice Scott M. Wilson*, Richard Yip*, Deborah A. Swing*, T. Norene O’Sullivan*, Yuke Zhang†, Edward K. Novak†, Richard T. Swank†, Liane B. Russell‡, Neal G. Copeland*, and Nancy A. Jenkins*§ *Mouse Cancer Genetics Program, National Cancer Institute–Frederick Cancer Research and Development Center, Frederick, MD 21702; †Department of Molecular and Cell Biology, Roswell Park Cancer Institute, Buffalo, NY 14263; and ‡Biology Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831 Contributed by Liane B. Russell, May 11, 2000 The dilute (d), leaden (ln), and ashen (ash) mutations provide a cells (9, 10). The absence of SER in spines probably disrupts unique model system for studying vesicle transport in mammals. the regulation of intracellular Ca2ϩ and postsynaptic signal All three mutations produce a lightened coat color because of transduction. defects in pigment granule transport. In addition, all three muta- A retroviral integration into the d gene in mice carrying the tions are suppressed by the semidominant dilute-suppressor (dsu), dilute-viral (dv) allele allowed the cloning of the d gene and the providing genetic evidence that these mutations function in the demonstration that d encodes an unconventional myosin heavy- same or overlapping transport pathways. Previous studies showed chain, myosin Va (MyoVa) (11, 12). MyoVa is expressed at high that d encodes a major vesicle transport motor, myosin-VA, which levels in nearly all tissues in the adult (12) and has the expected is mutated in Griscelli syndrome patients. Here, using positional structure for a member of this family—i.e., a globular head cloning and bacterial artificial chromosome rescue, we show that domain containing the ATP- and actin-binding sites, a ‘‘neck’’ ash encodes Rab27a. Rab GTPases represent the largest branch of domain, which is the site of calmodulin (or light-chain) binding, the p21 Ras superfamily and are recognized as key players in and a tail domain, which is thought to represent the cargo- vesicular transport and organelle dynamics in eukaryotic cells. We binding domain. MyoVa acts as a dimer and moves along actin also show that ash mice have platelet defects resulting in increased filaments in a plus-end-directed manner (13). Human MYOVA bleeding times and a reduction in the number of platelet dense mutations have also been identified and shown to produce GENETICS granules. These defects have not been reported for d and ln mice. Griscelli syndrome, a rare autosomal recessive disorder charac- Collectively, our studies identify Rab27a as a critical gene for terized by pigment dilution, variable cellular immunodeficiency, organelle-specific protein trafficking in melanocytes and platelets neurological defects, and acute phases of uncontrolled lympho- and suggest that Rab27a functions in both MyoVa dependent and cyte and macrophage activation (14). independent pathways. Yeast two-hybrid studies have shown that the tail domain of MyoVa can interact with a microtubule-based transport motor, ore than 50 loci in the mouse have been identified that ubiquitous kinesin heavy chain (KhcU) (15). Considerable bio- Maffect pigmentation of the coat (1). Three of these loci (d, logical and biochemical evidence indicates that long-range trans- ln, and ash) have been grouped together because they have an port in animal cells occurs on microtubules, whereas short-range identical phenotype: Pigment granule (melanosome) synthesis is transport occurs on actin filaments (16). An important question normal in these mice, but melanosome transport is abnormal (2). raised by these studies is how transport along these pathways is In wild-type mice, melanins are synthesized in melanosomes, coordinated. The yeast two-hybrid studies suggest that one way specialized organelles derived from the Golgi. The melanosomes this transport is coordinated is through the direct interaction of are then transported along the dendrites and exported to neigh- the different motor molecules. These data are consistent with boring keratinocytes in the hair bulb and subsequently to the hair previous studies, which showed that MyoVa and kinesin both can shaft (2, 3). In mice homozygous for these three recessive bind synaptic vesicles in the rat (17, 18) and that MyoVa is mutations, the melanosomes are localized mainly in the perinu- required for short-range, but not long-range, transport of smooth clear region of the melanocyte (3–5) resulting in the uneven endoplasmic reticulum in Purkinje cells (9, 10). release of pigment into the hair bulb and a lightened coat color. MyoVa has also been shown to bind to a novel RING finger Genetic evidence suggests that these loci encode proteins that protein BERP (19). It thus appears that MyoVa transports cargo function in the same or overlapping pathway. For example, mice as part of a complex involving several different proteins includ- homozygous for any double, or the triple, combinations of d, ln, ing KhcU and BERP. An intriguing possibility is that ash and ln and ash on the nonagouti background all have the same pheno- also encode proteins that function as part of this motor complex. type as mice homozygous for any of the individual mutations To determine whether this is the case, we have initiated the (N.G.C. and N.A.J., unpublished observations). In addition, all positional cloning of ash and ln. In studies described here, we three mutations are suppressed by the semidominant suppressor, present evidence to show that ash encodes Rab27a. Rab proteins dsu (6, 7). dsu was first recognized by its ability to suppress the are recognized as key players in vesicular transport and organelle coat color phenotype of d mice and in subsequent experiments dynamics in eukaryotic cells. was also shown to partially suppress the coat color phenotype of ash and ln mice (6). In all cases, the level of suppression could be correlated with the extent of the restoration of normal Abbreviations: MyoVa, myosin-VA; YAC, yeast artificial chromosome; SSLP, simple se- melanosome distribution. dsu has no phenotype on its own, is cell quence length polymorphism; BAC, bacterial artificial chromosome; HPS, Hermansky Pud- lak syndrome; CHM, choroideremia. autonomous (8), and can be seen only in combination with d, ash, Data deposition: The sequence reported in this paper has been deposited in the GenBank or ln. database (accession no. bankit332438). In addition to the melanosome transport defect, d null mice §To whom reprint requests should be addressed. E-mail: [email protected]. also show a neurological defect, characterized by opisthotonus The publication costs of this article were defrayed in part by page charge payment. This and ataxia, which results in the death of the animal 2–3 weeks article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. after birth. The neurological defect is thought to result from the §1734 solely to indicate this fact. failure to transport smooth endoplasmic reticulum (SER) from Article published online before print: Proc. Natl. Acad. Sci. USA, 10.1073͞pnas.140212797. the dendritic shaft to the dendritic spines of cerebellar Purkinje Article and publication date are at www.pnas.org͞cgi͞doi͞10.1073͞pnas.140212797 PNAS ͉ July 5, 2000 ͉ vol. 97 ͉ no. 14 ͉ 7933–7938 Downloaded by guest on September 28, 2021 Methods primers, which flank the fourth intron (nucleotides 259–280 and Mice. C3H͞HeSn-ash͞ash and Mus castaneus (CAST͞Ei) mice 449–426). PCR products were gel purified by using a GeneClean were purchased from The Jackson Laboratory and maintained III kit (BIO 101, Vista, CA) and then subjected to direct DNA and propagated at the National Cancer Institute–Frederick sequencing. In addition, aberrantly spliced Rab27a transcripts Cancer Research and Development Center, Frederick, MD. from the mutant strain were cloned and subjected to DNA Mice carrying the d-se deficiency chromosomes 13SaSd, sequencing. Sequencing was performed by using the Big Dye 11FHAFo, 19Zb, 1DTD, 9R250M, 37FBFo, 17Zb, and 10FD- Terminator Cycle Sequencing Ready Reaction Kit (Perkin– FoD were obtained from the Oak Ridge National Laboratory, Elmer), and data were acquired on an ABI Model 377 DNA Oak Ridge, TN. sequencer (Applied Biosystems). Genetic and Physical Maps. Genetic and yeast artificial chromo- Hematology. Bleeding times were determined by tail bleeding as some (YAC)-based physical maps of the ash critical region were described (26). Platelets were lysed in 1 ml distilled water and generated as described (20). A 129͞Sv bacterial artificial chro- assayed fluorimetrically for serotonin (27). Platelet-rich plasma was collected from citrated undiluted blood by centrifugation at mosome (BAC) library (Research Genetics, Huntsville, AL) was ϫ screened with the simple sequence length polymorphism (SSLP) 150 g for 10 min as described (26). Unfixed and unstained markers and YAC end probes derived from the ash critical platelets were rapidly air dried on carbon-coated grids before region. Positive BACs were end sequenced by using SP6 and T7 electron microscopy (28). promoter primers. PCR primer pairs, designed from the BAC Melanocyte Cell Culture. end sequence, were then used to construct a BAC contig of the Melanocyte cell lines were isolated from ash critical region. skin of mutant and wild-type mice as described (29). Results and Discussion Deficiency Mapping. To further refine the ash critical region, eight A Genetic and Physical Map of the ash-Critical Region. To initiate the deficiency chromosomes (21, 22) were tested for their ability to positional cloning of ash, we generated 897 (C3H͞HeSn-ash͞ complement ash by crossing mice carrying the deficiencies with ash ϫ Mus castaneus) ϫ C3H͞HeSn-ash͞ash N progeny, which C3H͞HeSn-ash͞ash mice. Three deficiency chromosomes 2 were typed at weaning for ash by visual inspection. Tail DNAs (13SaSd, 11FHAFo, 19Zb) complemented ash function, and from the mice were then typed for SSLP markers predicted to the remaining five deficiency chromosomes (1DTD, 9R250M, map near ash, defining an ash-critical interval of Ϸ0.3 cM or 37FBFo, 17Zb, 10FDFoD) did not.
Recommended publications
  • Exophilin-5 Regulates Allergic Airway Inflammation by Controlling IL-33–Mediated Th2 Responses
    The Journal of Clinical Investigation RESEARCH ARTICLE Exophilin-5 regulates allergic airway inflammation by controlling IL-33–mediated Th2 responses Katsuhide Okunishi,1 Hao Wang,1 Maho Suzukawa,2,3 Ray Ishizaki,1 Eri Kobayashi,1 Miho Kihara,4 Takaya Abe,4,5 Jun-ichi Miyazaki,6 Masafumi Horie,7 Akira Saito,7 Hirohisa Saito,8 Susumu Nakae,9 and Tetsuro Izumi1 1Laboratory of Molecular Endocrinology and Metabolism, Department of Molecular Medicine, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan. 2National Hospital Organization Tokyo National Hospital, Tokyo, Japan. 3Division of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan. 4Laboratory for Animal Resource Development and 5Genetic Engineering, RIKEN Center for Biosystems Dynamics Research, Kobe, Japan. 6Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan. 7Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. 8Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan. 9Laboratory of Systems Biology, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. A common variant in the RAB27A gene in adults was recently found to be associated with the fractional exhaled nitric oxide level, a marker of eosinophilic airway inflammation. The small GTPase Rab27 is known to regulate intracellular vesicle traffic, although its role in allergic responses is unclear. We demonstrated that exophilin-5, a Rab27-binding protein, was predominantly expressed in both of the major IL-33 producers, lung epithelial cells, and the specialized IL-5 and IL-13 producers in the CD44hiCD62LloCXCR3lo pathogenic Th2 cell population in mice.
    [Show full text]
  • Rab27a and Rab27b Control Different Steps of the Exosome Secretion Pathway
    ARTICLES Rab27a and Rab27b control different steps of the exosome secretion pathway Matias Ostrowski1,2, Nuno B. Carmo3,12, Sophie Krumeich1,2,12, Isabelle Fanget10,12, Graça Raposo4,2, Ariel Savina1,2, Catarina F. Moita3, Kristine Schauer4,2, Alistair N. Hume5, Rui P. Freitas3, Bruno Goud4,2, Philippe Benaroch1,2, Nir Hacohen8,9, Mitsunori Fukuda11, Claire Desnos10, Miguel C. Seabra5,6,7, François Darchen10, Sebastian Amigorena1,2, Luis F. Moita3,13 and Clotilde Thery1,2,13 Exosomes are secreted membrane vesicles that share structural and biochemical characteristics with intraluminal vesicles of multivesicular endosomes (MVEs). Exosomes could be involved in intercellular communication and in the pathogenesis of infectious and degenerative diseases. The molecular mechanisms of exosome biogenesis and secretion are, however, poorly understood. Using an RNA interference (RNAi) screen, we identified five Rab GTPases that promote exosome secretion in HeLa cells. Among these, Rab27a and Rab27b were found to function in MVE docking at the plasma membrane. The size of MVEs was strongly increased by Rab27a silencing, whereas MVEs were redistributed towards the perinuclear region upon Rab27b silencing. Thus, the two Rab27 isoforms have different roles in the exosomal pathway. In addition, silencing two known Rab27 effectors, Slp4 (also known as SYTL4, synaptotagmin-like 4) and Slac2b (also known as EXPH5, exophilin 5), inhibited exosome secretion and phenocopied silencing of Rab27a and Rab27b, respectively. Our results therefore strengthen the link between MVEs and exosomes, and introduce ways of manipulating exosome secretion in vivo. Exosomes are membrane vesicles secreted into the extracellular space membrane of MVEs into the lumen of these endosomes14.
    [Show full text]
  • The Genetics of Intellectual Disability: Whole Exome Sequencing to Find Causative Variants in Severe Cases
    Master’s Project in Medicine No 4362 The Genetics of Intellectual Disability: whole exome sequencing to find causative variants in severe cases Student Winteler Florence Supervisor Prof. Reymond Alexandre, Ph.D. Center for Integrative Genomics, UNIL Co-Supervisor Gueneau Lucie, Ph.D. Center for Integrative Genomics, UNIL Expert Prof. Draganski Bogdan, Dr. méd Département des neurosciences cliniques, CHUV Lausanne, 25.11.2017 Abstract Intellectual disability (ID) affects 1-3% of the population. A genetic origin is estimated to account for about half of the currently undiagnosed cases, and despite recent successes in identifying some of the genes, it has been suggested that hundreds more genes remain to be identified. ID can be isolated or part of a more complex clinical picture –indeed other symptoms are often found in patients with severe genetic ID, such as developmental delay, organ malformations or seizures. In this project, we used whole exome sequencing (WES) to analyse the coding regions of the genes (exons) of patients with undiagnosed ID and that of their families. The variants called by our algorithm were then grossly sorted out using criteria such as frequency in the general population and predicted pathogenicity. A second round of selection was made by looking at the relevant literature about the function of the underlying genes and pathways involved. The selected variants were then Sanger-sequenced for confirmation. This strategy allowed us to find the causative variant and give a diagnosis to the first family we analysed, as the patient was carrying a mutation in the Methyl-CpG binding protein 2 gene (MECP2), already known to cause Rett syndrome.
    [Show full text]
  • RAB27A Promotes Melanoma Cell Invasion and Metastasis Via Regulation of Pro
    RAB27A promotes melanoma cell invasion and metastasis via regulation of pro- invasive exosomes Dajiang Guo1,2*, Goldie Y. L. Lui1,2*, Siew Li Lai1, James S. Wilmott2,3, Shweta Tikoo1,2, Louise A. Jackett2,3,4, Camelia Quek3, Darren L. Brown5, Danae M. Sharp1,2, Rain Y.Q. Kwan1,2, Diego Chacon6,7, Jason H. Wong7,8, Dominik Beck6,7, Michelle van Geldermalsen1,2, Jeff Holst1,2, John F. Thompson2,3,4, Graham J. Mann3,9, Richard A. Scolyer2,3,4, Jennifer L. Stow5, Wolfgang Weninger1,10,11#, Nikolas K. Haass1,10,12#, Kimberley A. Beaumont1,2# 1The Centenary Institute, The University of Sydney, Newtown, NSW, Australia; Article 2Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia; 3Melanoma Institute Australia, The University of Sydney, North Sydney, NSW, Australia; 4Royal Prince Alfred Hospital, Camperdown, NSW, Australia; 5The Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia; 6Centre for Health Technologies and the School of Biomedical Engineering, University of Technology, Sydney, NSW, Australia; 7Adult Cancer Program, Lowy Cancer Research Centre, Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia; 8School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong; 9Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia; 10Discipline of Dermatology, The Accepted University of Sydney, Camperdown, NSW, Australia; 11Department of Dermatology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; 12The University of This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record.
    [Show full text]
  • Blueprint Genetics Comprehensive Immune and Cytopenia Panel
    Comprehensive Immune and Cytopenia Panel Test code: IM0901 Is a 642 gene panel that includes assessment of non-coding variants. Is ideal for patients with a clinical suspicion of an inborn error of immunity, such as, Primary Immunodeficiency, Bone Marrow Failure Syndrome, Dyskeratosis Congenita, Neutropenia, Thrombocytopenia, Hemophagocytic Lymphohistiocytosis, Autoinflammatory Disorders, Complement System Disorder, Leukemia, or Chronic Granulomatous Disease. This panel includes most genes from Primary Immunodeficiency, Severe Combined Immunodeficiency, Complement System Disorder, Bone Marrow Failure Syndrome, Hemophagocytic Lymphohistiocytosis, Congenital Neutropenia, Thrombocytopenia, Congenital Diarrhea, Chronic Granulomatous Disease, Diamond-Blackfan Anemia, Fanconi Anemia, Dyskeratosis Congenita, Autoinflammatory Syndrome, and Hereditary Leukemia Panels as well as many other genes associated with inborn errors of immunity. Please note that unlike our other panels, this panel is on our Whole Exome Sequencing platform and cannot be customized. Pricing may vary from our regular panel pricing. About immunodeficiency and cytopenia disorders There is an enormous amount of phenotypic overlap between immunological and hematological disorders, which makes it challenging to know which of these two systems is not functioning properly. Knowing the underlying genetic cause of a person’s clinical diagnosis, especially immunodeficiency, bone marrow failure, neutropenia, thrombocytopenia, autoinflammatory disease, or bone marrow failure can sometime
    [Show full text]
  • Download CGT Exome V2.0
    CGT Exome version 2.
    [Show full text]
  • Essential Role of Microphthalmia Transcription Factor for DNA Replication, Mitosis and Genomic Stability in Melanoma
    Oncogene (2011) 30, 2319–2332 & 2011 Macmillan Publishers Limited All rights reserved 0950-9232/11 www.nature.com/onc ORIGINAL ARTICLE Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma T Strub1,4, S Giuliano2,4,TYe1, C Bonet2, C Keime1, D Kobi1, S Le Gras1, M Cormont3, R Ballotti2, C Bertolotto2 and I Davidson1 1Institut de Ge´ne´tique et de Biologie Mole´culaire et Cellulaire, CNRS, INSERM, Universite´ de Strasbourg, Illkirch, France; 2INSERM U895 Team 1 and Department of Dermatology, CHU Nice, France and 3INSERM U895 Team 7, Nice, France Malignant melanoma is an aggressive cancer known use of internal promoters (Steingrimsson, 2008). The for its notorious resistance to most current therapies. MITF-M isoform (hereafter designated simply as The basic helix-loop-helix microphthalmia transcription MITF) is the major form produced specifically in the factor (MITF) is the master regulator determining the melanocyte lineage from an intronic promoter (Goding, identity and properties of the melanocyte lineage, and is 2000b). MITF is essential for the survival of melano- regarded as a lineage-specific ‘oncogene’ that has a blasts and postnatal melanocytes (McGill et al., 2002; critical role in the pathogenesis of melanoma. MITF Hou and Pavan, 2008), in which it also controls the promotes melanoma cell proliferation, whereas sustained expression of genes required for the melanin synthesis supression of MITF expression leads to senescence. (Bertolotto et al., 1998). By combining chromatin immunoprecipitation coupled to In addition to regulating multiple aspects of normal high throughput sequencing (ChIP-seq) and RNA sequen- melanocyte function, MITF also has a critical role in cing analyses, we show that MITF directly regulates a melanoma, in which it is required for survival, and set of genes required for DNA replication, repair and controls the proliferation, invasive and metastatic mitosis.
    [Show full text]
  • Griscelli Syndrome Type 2 Sine Albinism: Unraveling Differential RAB27A Effector Engagement
    ORIGINAL RESEARCH published: 10 December 2020 doi: 10.3389/fimmu.2020.612977 Griscelli Syndrome Type 2 Sine Albinism: Unraveling Differential RAB27A Effector Engagement Yuta Ohishi 1, Sandra Ammann 2,3, Vahid Ziaee 4,5, Katharina Strege 3, Miriam Groß 2, Carla Vazquez Amos 3, Mohammad Shahrooei 6, Parisa Ashournia 7, Anahita Razaghian 7, Gillian M. Griffiths 3, Stephan Ehl 2, Mitsunori Fukuda 1* and Nima Parvaneh 7,8* 1 Laboratory of Membrane Trafficking Mechanisms, Department of Integrative Life Sciences, Graduate School of Life Sciences, Tohoku University, Sendai, Japan, 2 Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Faculty of Medicine, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany, 3 Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom, 4 Department of Pediatrics, Tehran University of Medical Sciences (TUMS), Tehran, Iran, 5 Pediatric Rheumatology Research Group, Rheumatology Research Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran, 6 Laboratory of Clinical Bacteriology and Mycology, Department of Edited by: Microbiology and Immunology, KU Leuven, Leuven, Belgium, 7 Division of Allergy and Clinical Immunology, Department of Antonio Condino-Neto, Pediatrics, Tehran University of Medical Sciences (TUMS), Tehran, Iran, 8 Research Center for Immunodeficiencies, Tehran University of São Paulo, Brazil University of Medical Sciences (TUMS), Tehran, Iran Reviewed by: Alain Fischer, Griscelli syndrome type 2 (GS-2) is an inborn error of immunity characterized by partial Institut National de la Sante´ et de la Recherche Me´ dicale (INSERM), albinism and episodes of hemophagocytic lymphohistiocytosis (HLH). It is caused by France RAB27A mutations that encode RAB27A, a member of the Rab GTPase family.
    [Show full text]
  • Elucidation of Melanogenesis-Associated Signaling Pathways Regulated by Argan Press Cake in B16 Melanoma Cells
    nutrients Article Elucidation of Melanogenesis-Associated Signaling Pathways Regulated by Argan Press Cake in B16 Melanoma Cells Thouria Bourhim 1,‡ , Myra O. Villareal 2,3,‡ , Chemseddoha Gadhi 1,2,* and Hiroko Isoda 2,3,* 1 Faculty of Sciences Semlalia, Cadi Ayyad University, Avenue Prince Moulay Abdellah, B.P. 2390, Marrakesh 40000, Morocco; [email protected] 2 Alliance for Research on the Mediterranean and North Africa (ARENA), University of Tsukuba, Tennodai 1-1-1, Tsukuba 305-8572, Japan; [email protected] 3 Faculty of Life and Environmental Sciences, University of Tsukuba, Tennodai 1-1-1, Tsukuba 305-8572, Japan * Correspondence: [email protected] (C.G.); [email protected] (H.I.) ‡ These authors contributed equally to this work. Abstract: The beneficial effect on health of argan oil is recognized worldwide. We have previously reported that the cake that remains after argan oil extraction (argan press-cake or APC) inhibits melanogenesis in B16 melanoma cells in a time-dependent manner without cytotoxicity. In this study, the global gene expression profile of B16 melanoma cells treated with APC extract was determined in order to gain an understanding of the possible mechanisms of action of APC. The results suggest that APC extract inhibits melanin biosynthesis by down-regulating microphthalmia- associated transcription factor (Mitf ) and its downstream signaling pathway through JNK signaling activation, and the inhibition of Wnt/β-catenin and cAMP/PKA signaling pathways. APC extract also prevented the transport of melanosomes by down-regulating Rab27a expression. These results suggest that APC may be an important natural skin whitening product and pharmacological agent used for clinical treatment of pigmentary disorders.
    [Show full text]
  • Rab27a and Munc18 As Molecular Determinants of Snare- Mediated Vesicle Docking, Priming, and Fusion in Glucose Regulatory Tissues
    RAB27A AND MUNC18 AS MOLECULAR DETERMINANTS OF SNARE- MEDIATED VESICLE DOCKING, PRIMING, AND FUSION IN GLUCOSE REGULATORY TISSUES by Matthew J. Merrins A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Molecular and Integrative Physiology) in The University of Michigan 2008 Doctoral Committee: Professor Edward L. Stuenkel, Co-chair Associate Professor Richard M. Mortensen, Co-chair Professor John A. Williams Professor Robert T. Kennedy Assistant Professor Anatoli N. Lopatin TABLE OF CONTENTS LIST OF FIGURES iii ABSTRACT iv CHAPTER I. BACKGROUND 1 Introduction 1 Vesicle Fusion Machinery: SNARE proteins 8 Vesicle Docking and Priming Machinery: Role of Munc18 13 Vesicle Docking and Priming Machinery: Role of Rab27a 19 Statement of Hypothesis and Specific Aims 31 References 40 II. MUNC18C INTERACTION WITH SYNTAXIN4 MONOMERS AND SNARE COMPLEX INTERMEDIATES IN GLUT4 VESICLE TRAFFICKING 51 Abstract 51 Introduction 52 Experimental Procedures 55 Results 62 Discussion 73 Addendum: Molecular Characterization of Munc18 as a Syntaxin Chaperone 79 References 111 III. RAB27A-DEPENDENT ACTIONS ON VESICLE DOCKING AND PRIMING IN PANCREATIC β-CELLS 115 Abstract 115 Introduction 116 Experimental Procedures 118 Results 119 Discussion 128 References 143 IV. DISCUSSION 148 ii LIST OF FIGURES CHAPTER I: 1.1. Insulin signaling pathways regulating GLUT4 vesicle translocation. 34 1.2. Model of the neuronal SNARE core complex. 35 1.3. Comparison of Sec1/Munc18 (SM) protein crystal structures 36 1.4. Sites of Rab27a action within the pathways of glucose-stimulated insulin secretion in pancreatic β-cells. 37 1.5. Granule pools in the pancreatic β-cell 38 1.6.
    [Show full text]
  • Microphthalmia-Associated Transcription Factor (MITF) – from Waardenburg Syndrome Genetics to Melanoma Therapy
    Review article Microphthalmia-associated transcription factor (MITF) – from Waardenburg syndrome genetics to melanoma therapy Ivan Šamija, Josip Lukač, Zvonko Kusić Department of Oncology and Nuclear Medicine, Microphthalmia-associated transcription factor (MITF) was University Hospital “Sestre milosrdnice”, first discovered as protein coded by gene whose mutations Zagreb, Croatia are associated with Waardenburg syndrome. Later, MITF was shown to be key transcription factor regulating melanogen- esis. Further studies have shown that in addition to regulat- ing melanogenesis MITF also plays central role in regulation Corresponding author: of melanocyte development and survival. MITF gene is am- Ivan Šamija plified in a proportion of melanomas and ectopic MITF ex- Department of oncology and Nuclear Medicine pression can transform melanocytes so MITF can function University Hospital “Sestre milosrdnice” as melanoma “lineage survival” oncogene. Different studies Vinogradska cesta 29 have further revealed MITF’s important but complex role in 10000 Zagreb tumorigenesis and progression of melanoma. As expected Croatia from its important role in melanocytes and melanoma MITF [email protected] is intricately regulated on all the levels from transcription to Tel.: + 385 1 3787647 post-translational modifications. Although complex mecha- nisms of MITF functioning are still being revealed, MITF already has a valuable role in managing melanoma patients. Immunohistochemical analysis of MITF has shown both di- agnostic and prognostic value in patients with melanoma. MITF is also a valuable specific marker for detection of circu- lating melanoma cells by reverse-transcription – polymerase chain reaction. MITF has recently been investigated as a po- tential target for melanoma therapy. Key words: Microphthalmia-associated transcription fac- Received: 28 September 2010 tor, Melanoma, Melanocytes, Biological tumor markers, Accepted: 31 October 2010 Waardenburg’s syndrome.
    [Show full text]
  • Case Report Successful Treatment of Griscelli Syndrome with Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation
    Bone Marrow Transplantation (2002) 29, 995–998 2002 Nature Publishing Group All rights reserved 0268–3369/02 $25.00 www.nature.com/bmt Case report Successful treatment of Griscelli syndrome with unrelated donor allogeneic hematopoietic stem cell transplantation M Arico`1, M Zecca2, N Santoro3, D Caselli2, R Maccario2, C Danesino4, G de Saint Basile5 and F Locatelli2 1Onco Ematologia Pediatrica, Ospedale dei Bambini ‘G Di Cristina’, Palermo, Italy; 2Oncoematologia Pediatrica, IRCCS Policlinico San Matteo, Universita` di Pavia, Italy; 3Clinica Pediatrica, Universita` di Bari, Italy; 4Biologia Generale e Genetica Medica, Universita` di Pavia, Italy; and 5Institut National de la Sante et de la Recherche Medicale (INSERM) U429, Hopital Necker Enfants Malades, Paris, France Summary: show severe neurologic impairment, without apparent immune abnormalities.4 Griscelli syndrome (GS) is a rare autosomal recessive First reports of this new clinical entity, distinct from disorder, characterized by pigmentary dilution of the Chediak–Higashi syndrome (OMIM 214500) (CHS), were skin and hair and in most patients by abnormal regu- provided simultaneously in 1978 by Griscelli et al1 and by lation of the immune system, which results in a syn- Siccardi et al.2 drome of macrophage hyperactivation, known as hemo- In 1997 Pastural et al5 found a homozygous C2332T phagocytic lymophohistiocytosis (HLH). Allogeneic truncating mutation of the gene encoding myosin VA hematopoietic stem cell transplantation (HSCT) is the (MYO5A) in a Turkish girl with GS. Other mutations of the only curative treatment available for genetically same gene were reported in other cases. Recently, Pastural induced HLH. Few cases of successful HSCT from a et al6 presented evidence suggesting the existence of a compatible donor have been reported in children with second locus associated with Griscelli syndrome in the GS.
    [Show full text]